Read all the latest news headline updates on biocon stock. Get all the biocon stock breaking news updates, videos, photostories and more at Business Standard.

Biocon's stock declines despite acquiring Biocon Biologics as a wholly-owned subsidiary, reflecting mixed investor sentiment.

Tech Mahindra, Axis Bank, Godrej Properties, RITES, SIS, Jagsonpal Pharma, and Sterling and Wilson Renewable Energy are top ...

Solid earnings, robust biosimilars growth, and improving margins drive renewed optimism; analysts see double-digit upside ...

Watch Biocon and pharma stocks for a potential Nifty rebound as FIIs cover shorts—stay updated on key breakout levels!

Biocon shares fell 0.69% to ₹412.40 on Tuesday after completing the acquisition of 1,15,36,956 Biocon Biologics shares, ...

Kiran Mazumdar-Shaw says the company is expanding capacity to meet growing demand while major drugmakers prioritise newer therapies ...

Viatris Inc. , the company formed by the merger of Mylan and Pfizer Inc. unit Upjohn in 2020, said Monday it has reached an agreement to combine its biosimilars portfolio with Biocon Biologics Ltd.

Biocon's Malaysian partner Duopharma Biotech secures insulin supply contracts worth over MYR 225 million from Malaysia's ...

Biocon Biologics and Regeneron executed the settlement agreement to dismiss the pending appeal at the United States Court of Appeals for the Federal Circuit (USCAFC) of patent US11084865 ('865 patent) ...

Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the remaining stake in Biocon ...

Duopharma Biotech Bhd has secured over RM225mil worth of insulin supply contracts from the Health Ministry, with long-time ...